Edges in Network
| Network | GSE16446_top8000 - GSE16446 - SiGN-BN NNSR |
| Network Description | Predicting the efficacy of anthracyclines in breast cancer (BC) patients: The results of the TOP trial |
| Node | SPARCL1 |
| Upstream (Parents) |
|---|
| (<<) IGFBP7 → SPARCL1 |
| (<<) COL14A1 → SPARCL1 |
| (<<) PDGFD → SPARCL1 |
| (<<) LHFP → SPARCL1 |
| Downstream (Children) |
|---|
| SPARCL1 → LOC134466 (>>) |
| SPARCL1 → ARHGAP20 (>>) |
| SPARCL1 → GEM (>>) |
| SPARCL1 → NOVA1 (>>) |
| SPARCL1 → RBPMS (>>) |
| SPARCL1 → SCN4B (>>) |
| SPARCL1 → ABCG2 (>>) |
| SPARCL1 → RASL12 (>>) |
| SPARCL1 → C2orf40 (>>) |
| SPARCL1 → COL14A1 (>>) |
| SPARCL1 → FCER1A (>>) |
| SPARCL1 → FRZB (>>) |
| SPARCL1 → F2RL2 (>>) |
| SPARCL1 → RDH10 (>>) |
| SPARCL1 → CX3CR1 (>>) |
| SPARCL1 → MYH11 (>>) |
| SPARCL1 → HOXA5 (>>) |
| SPARCL1 → TNN (>>) |
| SPARCL1 → PDGFD (>>) |
| SPARCL1 → PGR (>>) |
| SPARCL1 → MEIS2 (>>) |
| SPARCL1 → LAMA2 (>>) |
| SPARCL1 → MAB21L1 (>>) |
| SPARCL1 → RAI2 (>>) |
| SPARCL1 → JAM2 (>>) |
